FUJIFILM Diosynth Biotechnologies Capacity Update February 2024: Cell & Gene

With the recent press release from FUJIFILM regarding the significant investment in cell therapy services, this webinar offers a glimpse into the flexible and smart designs included in the capacity expansion project at the Thousand Oaks facility. The existing Cell Therapy Center of Excellence came online for GMP production in 2018 and was acquired by FUJIFILM Diosynth Biotechnologies in April 2022. The expansion project will make use of the facilities existing footprint by adding new cleanrooms, updated development labs, expanded QC labs, and high efficiency warehousing solutions. This talk showcases examples of flexibility and state-of-the art designs to ensure that every Cell Therapy program, no matter where it is on the journey from discovery to marketing authorization, can be produced at Fujifilm Diosynth Biotechnologies California. By investing in cell therapy services, FUJFILM is committed to improving the lives of more patients through a true partnership mindset with our customers.